Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Combined modality therapy increasing local control of pancreatic cancer
Howard W. Bruckner
, Shalom Kalnicki
,
Jack Dalton
, Gary K. Schwartz
, Margaret R. Chesser
,
John Mandeli
, Cynthia Janus
Icahn School of Medicine at Mount Sinai
Radiation Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
30
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Combined modality therapy increasing local control of pancreatic cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pancreatic Cancer
100%
Radiotherapy
100%
Local Control
100%
Combined Modality Therapy
100%
5-fluorouracil (5-FU)
50%
Primary Tumor
33%
Tumor Shrinkage
33%
Most Common Cause
16%
Tumor
16%
Chemotherapy
16%
New Drugs
16%
Computed Tomography
16%
Primary Tumor Growth
16%
Cisplatin
16%
Surgical Intervention
16%
Continuous Infusion
16%
Streptozotocin
16%
Downstaging
16%
Multidrug Regimen
16%
Intraoperative Radiotherapy
16%
Tumor Regrowth
16%
Staging Criteria
16%
Locally Advanced Stage
16%
Historical Results
16%
Split Course
16%
Refractory Pain
16%
Early Palliative
16%
Medicine and Dentistry
Pancreas Cancer
100%
Multimodality Cancer Therapy
100%
Radiation Therapy
100%
Primary Tumor
50%
Neoplasm
50%
Fluorouracil
50%
Tumor Progression
16%
Combination Drug
16%
Computer Assisted Tomography
16%
Cisplatin
16%
Continuous Infusion
16%
Streptozocin
16%
Minoxidil
16%
Intraoperative Radiation Therapy
16%
Tumor
16%
Chemotherapy
16%
Treatment Modality
16%
Nursing and Health Professions
Pancreas Cancer
100%
Multimodality Cancer Therapy
100%
Radiotherapy
100%
Neoplasm
50%
Primary Tumor
50%
Fluorouracil
50%
Pilot Study
16%
Computer Assisted Tomography
16%
Continuous Infusion
16%
Minoxidil
16%
Tumor Growth
16%
Cisplatin
16%
Combination Drug
16%
Intraoperative Radiotherapy
16%
Streptozocin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
100%
Neoplasm
100%
Primary Tumor
100%
Fluorouracil
100%
Combination Drug
33%
Chemotherapy
33%
Tumor Growth
33%
Cisplatin
33%
Minoxidil
33%
Streptozotocin
33%
Immunology and Microbiology
Computer Assisted Tomography
100%